1. Zhang, Hang, Duan, Chao-Jun, Zhang, Heng, Cheng, Yuan-Da, Zhang, Chun-Fang. . Expression and clinical significance of REPS2 in human esophageal squamous cell carcinoma. In Asian Pacific journal of cancer prevention : APJCP, 14, 2851-7. doi:. https://pubmed.ncbi.nlm.nih.gov/23803043/
2. Doolan, P, Clynes, M, Kennedy, S, Crown, J, O'Driscoll, L. 2009. TMEM25, REPS2 and Meis 1: favourable prognostic and predictive biomarkers for breast cancer. In Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 30, 200-9. doi:10.1159/000239795. https://pubmed.ncbi.nlm.nih.gov/19776672/
3. Oosterhoff, Josien K, Penninkhof, Fred, Brinkmann, Albert O, Anton Grootegoed, J, Blok, Leen J. . REPS2/POB1 is downregulated during human prostate cancer progression and inhibits growth factor signalling in prostate cancer cells. In Oncogene, 22, 2920-5. doi:. https://pubmed.ncbi.nlm.nih.gov/12771942/
4. Oosterhoff, Josien K, Kühne, Liesbeth C, Grootegoed, J Anton, Blok, Leen J. . EGF signalling in prostate cancer cell lines is inhibited by a high expression level of the endocytosis protein REPS2. In International journal of cancer, 113, 561-7. doi:. https://pubmed.ncbi.nlm.nih.gov/15455380/
智鼠故事 
